Comparison of PSI, A-DROP, CURB-65, CRB-65, and SOAR indices in hospitalized patients with community acquired pneumonia Source: Annual Congress 2012 - Epidemiology: risk factors and prognosis in respiratory infections Year: 2012
Does the use of the CURB-65 score improve outcomes in community-acquired pneumonia (CAP)? Source: Annual Congress 2009 - Pulmonary infections Year: 2009
CUR-65 score for community-acquired pneumonia predicted mortality better than CURB-65 score in low-mortality-rate settings Source: International Congress 2015 – CAP: prognostic factors in frail patients Year: 2015
Validating CURB-65 score among inpatients with community acquired pneumonia in Pakistan Source: Eur Respir J 2006; 28: Suppl. 50, 351s Year: 2006
CURB 65 or CURB (S) 65 for community acquired pneumonia? Source: Annual Congress 2012 - Scores, biomarkers and risk factors in respiratory infections Year: 2012
Physicians should not use the pneumonia severity index (PSI) or CRB-65 in deciding the need for hospitalization in cancer patients with community-acquired pneumonia (CAP) Source: Eur Respir J 2007; 30: Suppl. 51, 41s Year: 2007
CURB-65 score predicted mortality in community-acquired pneumonia better than IDSA/ATS minor criteria in a low-mortality-rate setting Source: Annual Congress 2012 - Respiratory infections: prognosis and outcome Year: 2012
Role of procalcitonin (PCT) as a marker of severity of community acquired bacterial pneumonia (CABP) compared to PSI, CRB65 abd CURB65 Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections Year: 2013
Performance of early warning score and CURB-65 in predicting severe outcome in community-acquired pneumonia Source: International Congress 2016 – Monitoring comorbidities Year: 2016
Predicting severe sepsis in community-acquired pneumonia using CURB65 and PSI scores Source: Annual Congress 2008 - Diagnostic tests in lower respiratory tract infections Year: 2008
Birmingham Community Acquired Pneumonia Severity score (BCAPS) is a better predictor of mortality than CURB65 in hospitalised patients with community acquired pneumonia Source: Virtual Congress 2020 – Clinical challenges in pneumonia Year: 2020
Severe community-acquired pneumonia (CAP): validation of the IDSA/ATS guidelines to predict admission to the ICU Source: Annual Congress 2008 - Diagnosis and outcome in critically ill patients Year: 2008
Prognostic value of procalcitonin in community-acquired pneumonia Source: Eur Respir J 2011; 37: 384 Year: 2011
Weight of CURB-65 criteria for community-acquired pneumonia in a very low-mortality-rate setting Source: Annual Congress 2012 - Respiratory infections: prognosis and outcome Year: 2012
Reasons that justify hospitalization for community-acquired pneumonia (CAP) patients with CURB-65 score 0-1 Source: Annual Congress 2008 - Treatment and outcome in hospitalised patients with community-acquired pneumonia Year: 2008
Comorbidities and community acquired pneumonia (CAP) with PSI IV-V Source: Annual Congress 2010 - The spectrum of lower respiratory tract infections: risk factors of poor outcome and diagnostic tools Year: 2010
Severity assessment of community acquired pneumonia (CAP) using guidelines and prediction rule Source: Eur Respir J 2002; 20: Suppl. 38, 443s Year: 2002
Biomarkers and community acquired pneumonia (CAP) severity Source: Annual Congress 2010 - The prognosis of community-acquired pneumonia: old and new markers of severity Year: 2010
Biomarkers and community acquired pneumonia (CAP) severity Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia Year: 2011
The pneumonia severity index (PSI) do not underestimate the severity of community-acquired pneumonia (CAP) in young patients: results from the CAPO international study Source: Annual Congress 2008 - Factors related to outcome of community-acquired pneumonia Year: 2008